Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools

por Dhandapani, Muthu, Goldman, Aaron
Publicado 2017

Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients

por Robert, Beaulah Mary, Dakshinamoorthy, Muralidharan, Ganapathyagraharam Ramamoorthy, Brindha, Dhandapani, Muthu, Thangaiyan, Radhiga, Muthusamy, Ganesan, Nirmal, R. Madhavan, Prasad, Nagarajan Rajendra
Publicado 2018

Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2

por Brijwani, Nilesh, Jain, Misti, Dhandapani, Muthu, Zahed, Farrah, Mukhopadhyay, Pragnashree, Biswas, Manjusha, Khatri, Deepak, Radhakrishna, Vinod D., Majumder, Biswanath, Radhakrishnan, Padhma, Thiyagarajan, Saravanan
Publicado 2017

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

por Majumder, Biswanath, Baraneedharan, Ulaganathan, Thiyagarajan, Saravanan, Radhakrishnan, Padhma, Narasimhan, Harikrishna, Dhandapani, Muthu, Brijwani, Nilesh, Pinto, Dency D., Prasath, Arun, Shanthappa, Basavaraja U., Thayakumar, Allen, Surendran, Rajagopalan, Babu, Govind K., Shenoy, Ashok M., Kuriakose, Moni A., Bergthold, Guillaume, Horowitz, Peleg, Loda, Massimo, Beroukhim, Rameen, Agarwal, Shivani, Sengupta, Shiladitya, Sundaram, Mallikarjun, Majumder, Pradip K.
Publicado 2015